1. |
Aul C, Bowen DT, Pathogenesis YY. Etiology and epidemiology of myelodysplastic syndromes[J]. Haematologica, 1998, 83(1): 71-86.
|
2. |
Tefferi A, Myelodysplastic VJ. Syndromes[J]. N Engl J Med, 2009, 361(19): 1872-1885.
|
3. |
Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes[J]. Blood, 2009, 114(5): 937-951.
|
4. |
Greenberg P, Cox C, Lebeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes[J]. Blood, 1997, 89(6): 2079-2088.
|
5. |
Ulrich G, Judith N, Rainer H. The epidemiology of myelodysplastic syndromes[J]. Clinical Leukemia, 2008, 2(1): 34-38.
|
6. |
赵惠玲, 刘雁, 刘舒平. 骨髓增生异常综合征78例分析[J]. 实用医技杂志, 2006, 13( 09): 1488.
|
7. |
Ulrich G, Strupp C, Giagounidis A. Clinical features and prognosis of patients with myelodysplastic syndromes[J]. Cancer Treat Rev, 2007, 33(1): S15-S18.
|
8. |
中美联合上海市白血病协作组. 骨髓增生异常综合征435例WHO分型和细胞遗传学分析[J]. 中华内科杂志, 2008, 47(6): 464-467.
|
9. |
陈书长, 朱红, 庐荣, 等. 低增生骨髓增生异常综合征的由来和转归[J]. 中华内科杂志, 1999, 38(6): 9-11.
|
10. |
邱镜滢, 赖悦云, 柴晔, 等. 306例骨髓增生异常综合征染色体核型的研究[J]. 中国实验血液学杂志, 2004, 12(4): 455-459.
|
11. |
Chen B, Zhao WL, Jin J, et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries[J]. Leukemia, 2005, 19(5): 767-775.
|
12. |
Nishino HT, Chang CC. Myelodysplastic syndromes: clinicopathologic features, pathobiology, and molecular pathogenesis[J]. Arch Pathol Lab Med, 2005, 129(10): 1299-1310.
|
13. |
Germing U, Hildebrandt B, Pfeilstöcker M, et al. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)[J]. Leukemia, 2005, 19(12): 2223-2231.
|
14. |
Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and Life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making[J]. J Clin Oncol, 2005, 23(30): 7594-7603.
|
15. |
顾敏, 陈其文, 周永明, 等. MDS患者血浆SF, LDH, β2-MG水平临床观察[J]. 临床和实验医学杂志. 2011, 10(7): 503-504.
|